Thermo Fisher Scientific is flexing its diagnostic muscles in a booming clinical diagnostics market poised to hit $115.94 billion by 2030. Analysts are bullish on Thermo Fisher due to its recent $4.1 ...
Royal London Asset Management Ltd. trimmed its position in Danaher by a mere 0.5%, selling just 1,565 shares in Q4. Despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback